# Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia

> **NCT00643981** · PHASE1 · COMPLETED · sponsor: **TCA Cellular Therapy** · enrollment: 10 (estimated)

## Conditions studied

- Coronary Ischemia
- Coronary Disease
- Coronary Artery Disease
- Coronary Atherosclerosis
- Coronary Arteriosclerosis

## Interventions

- **BIOLOGICAL:** MESENDO

## Key facts

- **NCT ID:** NCT00643981
- **Lead sponsor:** TCA Cellular Therapy
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-12
- **Final completion:** 2009-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2011-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00643981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00643981, "Combination Stem Cell Therapy for the Treatment of Severe Coronary Ischemia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00643981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*